SUMMARY We used a radioenzymatic method to determine plasma levels of free and total (free plus sulfoconjugated) norepinephrine and dopamine in 20 children with neuroblastoma (two were hypertensive), seven patients with pheochromocytoma, and 39 normotensive controls (24 children and 15 adults). No significant differences were noted between the two control groups. Patients with neuroblastoma and pheochromocytoma showed significantly higher levels of free and total norepinephrine than controls ( p < 0.01), and those with pheochromocytoma had higher levels than those with neuroblastoma (p<0.01). Although the differences were not statistically significant, free dopamine was higher in both groups of patients than in controls. Total dopamine was significantly higher in patients than in controls (p<0.01). A positive correlation was noted between levels of total norepinephrine and total dopamine in controls (r = 0.41, p < 0.05) and in patients with neuroblastoma (r = 0.72, p < 0.001). Such a correlation was not found in patients with pheochromocytoma. The total dopamine/total norepinephrine ratio was higher ( p < 0.005) in patients with neuroblastoma than in controls and patients with pheochromocytoma. Patients with pheochromocytoma had significantly lower ratios than the other groups ( p < 0.001). A negative correlation was found between the ratios in the different groups and either systolic (p<0.001) or diastolic (p<0.001) blood pressure. Our results not only support a role for plasma dopamine hi the regulation of blood pressure but also suggest that, regardless of the actual levels of both catecholamines, a balance has to be achieved hi order to maintain normal blood pressure levels. High levels of free catecholamines in plasma have been reported in patients with both pheochromocytoma 31 4 and neuroblastoma. '•' High plasma levels of conjugated catecholamines have also been described in patients with pheochromocytoma. is the conjugation to sulfates.
T UMORS derived from the neural crest provide a suitable model for the study of catecholaminedependent hypertension. The symptoms of pheochromocytoma are caused by increased secretion of norepinephrine, epinephrine, or both. Hypertension is the most common clinical feature of this illness. In spite of the increased secretion of catecholamines,' patients with neuroblastoma very rarely develop symptoms of catecholamine excess (e.g., hypertension). 2 High levels of free catecholamines in plasma have been reported in patients with both pheochromocytoma 31 4 and neuroblastoma. '•' High plasma levels of conjugated catecholamines have also been described in patients with pheochromocytoma. 617 It was recently shown that an important metabolic pathway in the biotransformation of neurotransmitters is the conjugation to sulfates. 89 Some evidence suggests that sulfoconjugates are the only reversible metabolites of catecholamines, 10 and the possibility was raised that these conjugates are not mere end metabolites but have physiological activity." Furthermore, sulfoconjugated catecholamines, which have a longer half-life than free catecholamines, were suggested as useful markers of catecholamine release. 10 Alterations in the degree of conjugation were postulated in some patients with essential hypertension. 12 The present study was undertaken to evaluate whether the lack of hypertension observed in patients with neuroblastoma could be accounted for by either differences in or relationships between the catecholamines secreted.
Subjects and Methods Twenty children (11 boys and 9 girls, aged 17 days-9 years) with neuroblastoma and seven patients (2 men and 5 women, aged 9-45 years, with pheochromocytoma were studied. Diagnosis was established by analysis of urinary excretion of catecholamines and vanillylmandelic acid and confirmed by tumor histol-CATECHOLAMINES AND HYPERTENSION/Puyo et al. ogy. All but two patients with neuroblastoma were normotensive, while all those with pheochromocytoma had sustained hypertension.
Patients with neuroblastoma had not received any treatment prior to the study. Those with pheochromocytoma had not received any long-acting antihypertensive drug for at least 1 month prior to the study. Twenty-four normotensive children (15 boys and 9 girls, aged 6 months-14 years) randomly chosen from the tumor-free pediatric population of the hospital, and 15 normotensive adults (6 men and 9 women, aged 15-50 years) were the control groups. Previous written consent was given by all children's parents, adult patients, and controls.
Blood samples for simultaneous measurement of plasma total (free plus sulfoconjugated) dopamine and norepinephrine were drawn through an indwelling intravenous needle inserted 30 minutes before sampling, while subject rested in a supine position. In patients under 1 year of age the sample was taken by venipuncture. All samples were drawn between 0900 and 1000, and blood pressure was measured by a suitable sphygmomanometer at the time of sampling. Patients and controls over age 1 year had been fasting for 12 hours prior to the sampling. Infants were tested immediately before their feeding. Blood was poured into plastic tubes kept on ice, containing 20 /xiyml of a solution of reduced glutathione and EGTA in water. 13 Free plasma catecholamines were assayed in duplicate by our modification 14 of the radioenzymatic method of Da Prada and Zurcher." The assay for total catecholamines (free plus conjugated) paralleled the one used for free catecholamines, except that an aliquot of sulfatase was added to the incubation mixture, as described by Johnson et al. 9 Differences among values were evaluated by unpaired t test and correlations were calculated.
Results
Plasma levels of both free and total norepinephrine and dopamine, the ratio of total dopamine to total norepinephrine, and systolic and diastolic blood pressures in the four groups studied are shown in Table 1 . The levels of free and total norepinephrine and dopamine in the two groups of controls were found to be similar. Patients with neuroblastoma and pheochromocytoma showed significantly higher ( / J < 0 . 0 1 ) levels of free and total norepinephrine than did controls. Mean levels of free and total norepinephrine in patients with pheochromocytoma were significantly higher (p<0.01) than in those with neuroblastoma.
Although mean plasma free dopamine was higher in both groups of patients than in controls, significant differences were not found due to the wide scatter of values. Total dopamine was significantly higher ( p < 0.01) in both groups of patients than in controls, and significantly higher in those with neuroblastoma (p< 0.02) than in those with pheochromocytoma. The ratio of total dopamine to total norepinephrine in patients with neuroblastoma was significantly higher (p< 0.005) than in control children, control adults, and patients with pheochromocytoma. The ratio in the pheochromocytoma group was significantly lower (p<0.001) than in either control or neuroblastoma groups. Figures 1 and 2 show the individual levels of free and total plasma norepinephrine and dopamine found in the four groups studied. All patients with pheochromocytoma had levels of free and total norepinephrine above the range found in controls. Seven with neuroblastoma had levels of free norepinephrine within the range observed in those with pheochromocytomas; five of them also had levels of total norepinephrine overlapping those of patients with pheochromocytoma. Only 
FIGURE 1. Mean and individual levels of free (*) and total (o) plasma norepinephrine (NE). Patients with neuroblastoma and pheochromocytoma showed significantly higher (p<0.01) leyels of free and total norepinephrine than did controls. Levels of free and total norepinephrine in patients with pheochromocytoma were significantly higher (p<0.01) than in those with neuroblastoma. Free (A) and total (A) plasma norepinephrine in hypertensive patients with neuroblastoma.
two of the patients with neuroblastoma who had high levels of norepinephrine were hypertensive. One was a 3-month-old boy who had extraordinarily high blood pressure, with paroxysms reaching 300 mm Hg, and also the highest norepinephrine values. The other, a 19-month-old girl, had sustained hypertension (150/100 mm Hg). Blood pressure levels in the remaining patients were not different from those Observed in the patients whose norepinephrine levels were within the range of the control group. All patients with pheochromocytoma had levels of free dopamine within the range observed in those with neuroblastoma, whereas the levels of total dopamine in all the patients of the former group were well below the mean value found in the latter. Moreover, total dopamine levels in two patients with pheochromocytoma overlapped the lowest values found in controls.
In control subjects, both children and adults, total plasma norepinephrine was positively correlated with total plasma dopamine (r = 0.41, /?<0.05). A positive correlation (r = 0.72, />< 0.001) also was found in the neuroblastoma group but not in the pheochromocytoma group (Figure 3) .
Both systolic ( r = -0.62, p<0.001) and diastolic (r = -0.64, p<0.001) blood pressures were found to be negatively correlated with the log total dopamine/total norepinephrine ratio in the groups studied.
Discussion
Our study shows that in spite of having high levels of circulating norepinephrine (free, total, or both), only a small percentage of patients with neuroblastoma developed hypertension. The lack of hypertension in these patients has been observed before 16 and was explained by the metabolization of the amines inside the tumor. Nevertheless, this explanation does not take into account the high urinary and plasma norepinephrine levels found in these patients. Seven of the 20 patients with neuroblastoma had levels of norepinephrine in the range of those found in patients with pheochromocytoma, but only two of them were hypertensive. It has also been noted that patients with neuroblastoma excreted large amounts of dopamine and dopamine metabolites. "•" Furthermore, increased levels of free plasma dopamine 1 were reported in these patients, and increased levels of conjugated dopamine were found in a pool of plasma from patients with neuroblastoma. 9 In the patients in the present study, levels of both free and total plasma dopamine were found to be elevated.
After the earlier demonstration of the role of norepinephrine as a hypertensive agent, a role for dopamine as a balancing force was suggested. Further evidence supporting this suggestion was later provided by the finding of the blood pressure-lowering effect of dopamine infusion in hypertensive patients, 19 and the effects of bromocriptine, a dopamine agonist, which DA ng/ml as as C-CMIdr«n C Adultt H«uroW*ttonu PtwoOmjmocyt. 20 and hypertensive 21 patients. Studies of the hypertension of pheochromocytoma patients also suggested that dopamine could have opposite effects to those of norepinephrine. 22 The lack of hypertension in neuroblastoma patients could then be related to the high levels of dopamine found in these patients. Nevertheless, some patients with pheochromocytoma also showed high levels of circulating dopamine.
FIGURE 2. Mean and individual levels of free C) and total (o) plasma dopamine (DA
Perhaps a better approach to the study of the hypertension in these patients is achieved by analysis of the total dopamine/total norepinephrine ratio. This ratio, on the other hand, has been considered to be a better reflection of sympathetic discharge than is free norepinephrine alone. 23 The ratios found in the groups of patients of this study were quite different, and a negative correlation was noted between them and both systolic and diastolic blood pressures. The finding of these correlations gives further support to the use of this ratio in analyzing catecholamine-dependent hypertension. In agreement with our previous study, 7 ratios found in hypertensive patients with pheochromocytoma were very low, while they were high in normotensive patients with neuroblastoma. Ratios in a group of patients with pheochromocytoma and paroxysmal hypertension studied during the normotensive period were similar to those found in controls. 7 One of the two hypertensive patients with neuroblastoma showed a ratio in the range of those found in patients with pheochromocytoma, while the other showed a somewhat higher ratio that overlapped the lower values of the control group.
The finding of the positive correlation between total dopamine and total norepinephrine in controls, both children and adults, as well as in normotensive patients with neuroblastoma suggests that a balance has to be achieved in order to maintain normal blood pressure levels. Although such a correlation has not been reported previously, the 24-hour urinary excretion of DA ng/ml dopamine was found to be correlated with that of norepinephrine. 24 In some patients undergoing a neurosurgical operation, a significant correlation was found between free plasma dopamine and free plasma norepinephrine, as well as between conjugated dopamine and both free dopamine and norepinephrine in patients after a subarachnoid hemorrhage, an event associated with sympathetic stimulation. 23 Although many other factors are involved in blood pressure regulation, our results not only support a role of plasma dopamine in the control of blood pressure but also suggest that regardless of the actual levels of catecholamines, a balance has to be achieved in order to maintain normal blood pressure levels.
